Variant report

Variant	nsv579602
Chromosome Location	chr19:42015468-42047924
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:714)
CpG islands
(count:244)
Chromatin interactive
region (count:9)
LncRNA
region (count:13)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:714 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:42044288-42044433	K562	blood:	n/a	n/a
2	ATF1	chr19:42037809-42038256	K562	blood:	n/a	n/a
3	ATF1	chr19:42034637-42034760	K562	blood:	n/a	n/a
4	ATF1	chr19:42032569-42032575	K562	blood:	n/a	n/a
5	ATF1	chr19:42046751-42046881	K562	blood:	n/a	n/a
6	ATF2	chr19:42041202-42042096	GM12878	blood:	n/a	n/a
7	ATF2	chr19:42037562-42038519	GM12878	blood:	n/a	n/a
8	ATF2	chr19:42041209-42041983	GM12878	blood:	n/a	n/a
9	BACH1	chr19:42016903-42017186	K562	blood:	n/a	n/a
10	BATF	chr19:42022723-42023153	GM12878	blood:	n/a	n/a
11	BATF	chr19:42037778-42038228	GM12878	blood:	n/a	n/a
12	BATF	chr19:42027836-42028322	GM12878	blood:	n/a	n/a
13	BATF	chr19:42041513-42041943	GM12878	blood:	n/a	n/a
14	BATF	chr19:42027742-42028251	GM12878	blood:	n/a	n/a
15	BCL11A	chr19:42041523-42041834	GM12878	blood:	n/a	n/a
16	BCL11A	chr19:42041151-42041932	GM12878	blood:	n/a	n/a
17	BCL11A	chr19:42022922-42023098	GM12878	blood:	n/a	n/a
18	BCL3	chr19:42016667-42016907	GM12878	blood:	n/a	n/a
19	BCL3	chr19:42041346-42042017	GM12878	blood:	n/a	n/a
20	BCL3	chr19:42016314-42016648	GM12878	blood:	n/a	n/a
21	BCL3	chr19:42016218-42016628	GM12878	blood:	n/a	n/a
22	BCLAF1	chr19:42041201-42042022	GM12878	blood:	n/a	n/a
23	BCLAF1	chr19:42027598-42028326	GM12878	blood:	n/a	n/a
24	BCLAF1	chr19:42037618-42038574	GM12878	blood:	n/a	n/a
25	BHLHE40	chr19:42028460-42028816	GM12878	blood:	n/a	chr19:42028587-42028603 chr19:42028585-42028601
26	BHLHE40	chr19:42022983-42023012	GM12878	blood:	n/a	n/a
27	BHLHE40	chr19:42041299-42041952	GM12878	blood:	n/a	n/a
28	CEBPB	chr19:42038006-42038343	K562	blood:	n/a	n/a
29	CEBPB	chr19:42038111-42038379	A549	lung:	n/a	n/a
30	CEBPB	chr19:42022644-42023024	HepG2	liver:	n/a	chr19:42022803-42022814
31	CEBPB	chr19:42022693-42022893	IMR90	lung:	n/a	chr19:42022803-42022814
32	CEBPB	chr19:42037315-42037604	MCF-7	breast:	n/a	n/a
33	CEBPB	chr19:42022705-42022860	HepG2	liver:	n/a	chr19:42022803-42022814
34	CEBPB	chr19:42022763-42022875	Hela-S3	cervix:	n/a	chr19:42022803-42022814
35	CEBPB	chr19:42041130-42042105	GM12878	blood:	n/a	n/a
36	CEBPB	chr19:42022688-42022956	K562	blood:	n/a	chr19:42022803-42022814
37	CEBPB	chr19:42022680-42022977	A549	lung:	n/a	chr19:42022803-42022814
38	CHD1	chr19:42041480-42041892	GM12878	blood:	n/a	n/a
39	CHD1	chr19:42036311-42036390	GM12878	blood:	n/a	n/a
40	CHD2	chr19:42041407-42041846	GM12878	blood:	n/a	n/a
41	CREB1	chr19:42041278-42042051	GM12878	blood:	n/a	n/a
42	CREB1	chr19:42037728-42038519	GM12878	blood:	n/a	n/a
43	CREB1	chr19:42037640-42038535	GM12878	blood:	n/a	n/a
44	CREB1	chr19:42037826-42038212	A549	lung:	n/a	n/a
45	CTCF	chr19:42044185-42044547	A549	lung:	n/a	n/a
46	CTCF	chr19:42044252-42044470	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr19:42044200-42044350	HCM	heart:	n/a	n/a
48	CTCF	chr19:42043987-42043996	GM19240	blood:	n/a	n/a
49	CTCF	chr19:42044261-42044372	Medullo	brain:	n/a	n/a
50	CTCF	chr19:42023166-42023511	GM12891	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42028551-42028601	K562	blood:	n/a
2	chr19:42027798-42027848	HEK293	kidney:	embryo
3	chr19:42027798-42027848	LNCaP	prostate:	n/a
4	chr19:42027798-42027848	HEEpiC	esophagus:	n/a
5	chr19:42027798-42027848	U87	brain:	n/a
6	chr19:42031482-42031532	HepG2	liver:	n/a
7	chr19:42027798-42027848	HepG2	liver:	n/a
8	chr19:42026012-42026062	HCM	heart:	n/a
9	chr19:42031482-42031532	NHDF-neo	bronchial:	n/a
10	chr19:42031482-42031532	U87	brain:	n/a
11	chr19:42031482-42031532	ovcar-3	ovarian:	n/a
12	chr19:42026012-42026062	AG04450	lung:	fetal
13	chr19:42027798-42027848	MCF10A-Er-Src	breast:	n/a
14	chr19:42028551-42028601	HCF	heart:	n/a
15	chr19:42027798-42027848	HCM	heart:	n/a
16	chr19:42026012-42026062	Hepatocyte	liver:	n/a
17	chr19:42028551-42028601	AG10803	skin:	n/a
18	chr19:42026012-42026062	AG10803	skin:	n/a
19	chr19:42031482-42031532	SK-N-SH_RA	brain:	n/a
20	chr19:42027798-42027848	AG04450	lung:	fetal
21	chr19:42026012-42026062	A549	lung:	n/a
22	chr19:42026012-42026062	SKMC	muscle:	n/a
23	chr19:42028551-42028601	A549	lung:	n/a
24	chr19:42027798-42027848	GM06990	blood:	n/a
25	chr19:42031482-42031532	HRCEpiC	kidney:	n/a
26	chr19:42028551-42028601	AG04449	skin:	fetal
27	chr19:42031482-42031532	HAEpiC	amniotic membrane:	n/a
28	chr19:42026012-42026062	GM12892	blood:	n/a
29	chr19:42028551-42028601	MCF10A-Er-Src	breast:	n/a
30	chr19:42027798-42027848	K562	blood:	n/a
31	chr19:42028551-42028601	SAEC	small airway:	n/a
32	chr19:42028551-42028601	GM12878	blood:	n/a
33	chr19:42026012-42026062	HRPEpiC	eye:	n/a
34	chr19:42028551-42028601	HNPCEpiC	eye:	n/a
35	chr19:42028551-42028601	NB4	blood:	n/a
36	chr19:42026012-42026062	AG09309	skin:	n/a
37	chr19:42028551-42028601	MCF-7	breast:	n/a
38	chr19:42031482-42031532	Hela-S3	cervix:	n/a
39	chr19:42031482-42031532	HNPCEpiC	eye:	n/a
40	chr19:42031482-42031532	A549	lung:	n/a
41	chr19:42031482-42031532	HIPEpiC	eye:	n/a
42	chr19:42028551-42028601	HEEpiC	esophagus:	n/a
43	chr19:42031482-42031532	AG09319	gingival:	n/a
44	chr19:42028551-42028601	HCT-116	colon:	n/a
45	chr19:42027798-42027848	HCPEpiC	choroid plexus:	n/a
46	chr19:42028551-42028601	PANC-1	pancreas:	n/a
47	chr19:42028551-42028601	AG09319	gingival:	n/a
48	chr19:42026012-42026062	AG04449	skin:	fetal
49	chr19:42031482-42031532	HPAEpiC	pulmonary alveolar:	n/a
50	chr19:42031482-42031532	NT2-D1	testis:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:42031680..42033653-chr19:42037544..42040304,2	K562	blood:
2	chr19:42035785..42038762-chr19:42042099..42044984,2	MCF-7	breast:
3	chr19:41955365..41955940-chr19:42043884..42044391,2	K562	blood:
4	chr19:42032930..42034561-chr19:42036519..42039384,2	MCF-7	breast:
5	chr19:41955214..41955908-chr19:42043733..42044434,2	MCF-7	breast:
6	chr19:42031680..42033853-chr19:42037171..42039044,2	K562	blood:
7	chr19:41970790..41973417-chr19:42039173..42040939,2	K562	blood:
8	chr19:41955066..41955972-chr19:42043125..42044734,10	MCF-7	breast:
9	chr19:42044232..42044742-chr19:42076655..42077555,2	MCF-7	breast:

(count:13 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CEACAM21-2	chr19:42042076-42042145	ENSG00000270164.1
2	lnc-CEACAM21-2	chr19:42042090-42042145	ENSG00000270164.1
3	lnc-CEACAM21-2	chr19:42041860-42041963	ENSG00000270164.1
4	lnc-CEACAM21-3	chr19:42037647-42037935	ENSG00000268355.1
5	lnc-CEACAM21-3	chr19:42037786-42038237	ENSG00000268355.1
6	lnc-CEACAM21-2	chr19:42042960-42043266	ENSG00000270164.1
7	lnc-CEACAM21-3	chr19:42037566-42037693	ENSG00000268355.1
8	lnc-CEACAM21-2	chr19:42041702-42042145	ENSG00000270164.1
9	lnc-CEACAM21-2	chr19:42041929-42041963	ENSG00000270164.1
10	lnc-CEACAM21-2	chr19:42042960-42043264	ENSG00000270164.1
11	lnc-CEACAM21-2	chr19:42041545-42043262	ENSG00000270164.1
12	lnc-CEACAM21-3	chr19:42038230-42038534	ENSG00000268355.1
13	lnc-CEACAM21-2	chr19:42042963-42043266	ENSG00000270164.1

No data

Variant related genes	Relation type
ENSG00000270164	TF binding region
ENSG00000268355	TF binding region
ENSG00000268027	TF binding region
PLEKHA3P1	TF binding region
ENSG00000270164	CpG island
ENSG00000268355	CpG island
ENSG00000268027	CpG island
PLEKHA3P1	CpG island
ENSG00000268355	chromatin interactions

Extended variants
information (count: 1039 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:1039 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs542695964	chr19:42022221-42022222	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs185748455	chr19:42022222-42022223	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs376642810	chr19:42022234-42022235	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs10406545	chr19:42022245-42022246	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs10406371	chr19:42022289-42022290	Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
6	rs549749525	chr19:42022296-42022297	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs189650338	chr19:42022339-42022340	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs567408397	chr19:42022343-42022344	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs141661863	chr19:42022353-42022354	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs556177474	chr19:42022369-42022370	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs575772318	chr19:42022380-42022381	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs539990802	chr19:42022389-42022390	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs558203953	chr19:42022392-42022393	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs573180116	chr19:42022398-42022399	Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs540280274	chr19:42022416-42022417	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs555335625	chr19:42022428-42022429	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs181555023	chr19:42022443-42022444	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs10406988	chr19:42022444-42022445	Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
19	rs146177032	chr19:42022467-42022468	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs532985586	chr19:42022491-42022492	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs533012311	chr19:42022502-42022503	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs117826828	chr19:42022508-42022509	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs560233215	chr19:42022516-42022517	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs374139932	chr19:42022521-42022522	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs577976039	chr19:42022522-42022523	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs372919291	chr19:42022524-42022525	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs201306271	chr19:42022526-42022527	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs200242434	chr19:42022530-42022531	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs527575092	chr19:42022534-42022535	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs114131575	chr19:42022535-42022536	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs567274068	chr19:42022569-42022570	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs186275407	chr19:42022585-42022586	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs549626999	chr19:42022593-42022594	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs139130801	chr19:42022615-42022616	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs191227917	chr19:42022643-42022644	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs370221710	chr19:42022649-42022650	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs77991429	chr19:42022700-42022701	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs537340768	chr19:42022715-42022716	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs566868375	chr19:42022731-42022732	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs534222632	chr19:42022738-42022739	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs386809374	chr19:42022777-42022778	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs182265080	chr19:42022779-42022780	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs186469081	chr19:42022781-42022782	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs12459986	chr19:42022794-42022795	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs111987591	chr19:42022852-42022853	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs73558696	chr19:42022871-42022872	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs578046125	chr19:42022887-42022888	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs150918038	chr19:42022915-42022916	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs548748904	chr19:42022926-42022927	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs527436275	chr19:42022942-42022943	Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD
Schizophrenia	18511947	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:617 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:42022200-42022400	Bivalent Enhancer	Primary B cells from cord blood	blood
2	chr19:42022200-42023000	Enhancers	Primary B cells from peripheral blood	blood
3	chr19:42022400-42022600	Enhancers	Spleen	Spleen
4	chr19:42022400-42022800	Bivalent Enhancer	HepG2	liver
5	chr19:42022400-42022800	Enhancers	Monocytes-CD14+_RO01746	blood
6	chr19:42022400-42023200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr19:42022400-42023200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr19:42022400-42023400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
9	chr19:42022400-42023400	Enhancers	Placenta Amnion	Placenta Amnion
10	chr19:42022400-42023600	Enhancers	GM12878-XiMat	blood
11	chr19:42022400-42023800	Enhancers	Primary monocytes fromperipheralblood	blood
12	chr19:42022400-42023800	Enhancers	Primary hematopoietic stem cells short term culture	blood
13	chr19:42022400-42024000	Enhancers	Primary B cells from cord blood	blood
14	chr19:42022600-42022800	Bivalent Enhancer	Rectal Mucosa Donor 29	rectum
15	chr19:42022800-42023000	Bivalent Enhancer	Fetal Kidney	kidney
16	chr19:42022800-42023600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
17	chr19:42022800-42023800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
18	chr19:42023000-42023200	Flanking Active TSS	Primary B cells from peripheral blood	blood
19	chr19:42023000-42023600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
20	chr19:42023200-42023400	Enhancers	Primary B cells from peripheral blood	blood
21	chr19:42023200-42023400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
22	chr19:42023200-42023400	Enhancers	Adipose Nuclei	Adipose
23	chr19:42023200-42023400	Enhancers	Spleen	Spleen
24	chr19:42023200-42023600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
25	chr19:42023200-42023600	Enhancers	Primary T helper cells fromperipheralblood	blood
26	chr19:42023200-42023600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
27	chr19:42023200-42023800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
28	chr19:42023200-42023800	Enhancers	Primary T helper cells PMA-I stimulated	--
29	chr19:42023200-42023800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
30	chr19:42023200-42023800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr19:42023200-42023800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr19:42023400-42023600	Flanking Active TSS	Primary B cells from peripheral blood	blood
33	chr19:42023400-42023600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
34	chr19:42023400-42023600	Flanking Active TSS	Adipose Nuclei	Adipose
35	chr19:42023400-42023600	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
36	chr19:42023400-42023800	Bivalent Enhancer	Duodenum Mucosa	Duodenum
37	chr19:42023600-42023800	Enhancers	Primary B cells from peripheral blood	blood
38	chr19:42023600-42023800	Active TSS	Adipose Nuclei	Adipose
39	chr19:42023600-42023800	Enhancers	Monocytes-CD14+_RO01746	blood
40	chr19:42023600-42027000	Weak transcription	GM12878-XiMat	blood
41	chr19:42023600-42027600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
42	chr19:42023800-42026200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
43	chr19:42023800-42026400	Weak transcription	Primary B cells from peripheral blood	blood
44	chr19:42023800-42026600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr19:42023800-42026800	Weak transcription	Monocytes-CD14+_RO01746	blood
46	chr19:42023800-42027000	Weak transcription	Primary monocytes fromperipheralblood	blood
47	chr19:42023800-42027600	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
48	chr19:42024000-42027000	Weak transcription	Primary B cells from cord blood	blood
49	chr19:42025600-42027400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
50	chr19:42026200-42027400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links